Therapeutic activity of bivalent BRD4 inhibitor AZD5153 in hematological cancers

被引:0
|
作者
Chen, Huawei Ray
Hattersley, Maureen
Rhyasen, Garrett
Dulak, Austin
Wang, Wendy
Petteruti, Phil
Dale, Ian
Cheung, Tony
Wen, Shenghua
Castriotta, Lilian
Lawson, Deborah
Collins, Mike
Ahdesmaki, Miika
Walker, Graeme
Rabow, Al
Dry, Jonathan
Reimer, Corinne
Lyne, Paul
Fawell, Steve
Waring, Mike
Zinda, Mike
Clark, Ed
Clark, Ed
机构
关键词
D O I
10.1158/1538-7445.AM2016-4705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4705
引用
收藏
页数:3
相关论文
共 50 条
  • [1] AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells
    Lin, Cho-Hao
    Kuo, Jimmy Chun-Tien
    Li, Ding
    Koenig, Aaron B.
    Pan, Alexander
    Yan, Pearlly
    Bai, Xue-Feng
    Lee, Robert J.
    Ghoshal, Kalpana
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [2] BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor
    Zhang, Peng
    Li, Ruidong
    Xiao, Hua
    Liu, Weizhen
    Zeng, Xiangyu
    Xie, Genchen
    Yang, Wenchang
    Shi, Liang
    Yin, Yuping
    Tao, Kaixiong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (09): : 1942 - 1954
  • [3] AZD5153, a novel BRD4 inhibitor, suppresses human thyroid carcinoma cell growth in vitro and in vivo
    Xu, Kun
    Chen, Dexuan
    Qian, Dong
    Zhang, Shihu
    Zhang, Yi
    Guo, Song
    Ma, Zhaoqun
    Wang, Shui
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 499 (03) : 531 - 537
  • [4] BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages
    Li, Xi
    Fu, Yu
    Yang, Bin
    Guo, Ensong
    Wu, Yifan
    Huang, Jia
    Zhang, Xiaoxiao
    Xiao, Rourou
    Li, Kezhen
    Wang, Beibei
    Hu, Junbo
    Sun, Chaoyang
    Chen, Gang
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [5] AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
    Rhyasen, Garrett W.
    Hattersley, Maureen M.
    Yao, Yi
    Dulak, Austin
    Wang, Wenxian
    Petteruti, Philip
    Dale, Ian L.
    Boiko, Scott
    Cheung, Tony
    Zhang, Jingwen
    Wen, Shenghua
    Castriotta, Lillian
    Lawson, Deborah
    Collins, Michael
    Bao, Larry
    Ahdesmaki, Miika J.
    Walker, Graeme
    O'Connor, Greg
    Yeh, Tammie C.
    Rabow, Alfred A.
    Dry, Jonathan R.
    Reimer, Corinne
    Lyne, Paul
    Mills, Gordon B.
    Fawell, Stephen E.
    Waring, Michael J.
    Zinda, Michael
    Clark, Edwin
    Chen, Huawei
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (11) : 2563 - 2574
  • [6] BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor (vol 15, pg 1942, 2019)
    Zhang, Peng
    Li, Ruidong
    Xiao, Hua
    Liu, Weizhen
    Zeng, Xiangyu
    Xie, Genchen
    Yang, Wenchang
    Shi, Liang
    Yin, Yuping
    Tao, Kaixiong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (09): : 3795 - 3797
  • [7] First-in-human study of AZD5153, a small molecule inhibitor of bromodomain protein 4 (BRD4), in patients (pts) with relapsed/refractory (RR) malignant solid tumor and lymphoma: Preliminary data.
    Wang, Judy Sing-Zan
    De Vita, Serena
    Karlix, Janet L.
    Cook, Carl
    Littlewood, Gillian M.
    Hattersley, Maureen M.
    Moorthy, Ganesh
    Edlund, Helena
    Fabbri, Giulia
    Sachsenmeier, Kris F.
    Davison, Chris
    Clark, Edwin
    Moore, Kathleen N.
    Bauer, Todd Michael
    Ulahannan, Susanna Varkey
    Patel, Manish R.
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] The therapeutic potential of BRD4 in cardiovascular disease
    Lin, Shigang
    Du, Lizhong
    HYPERTENSION RESEARCH, 2020, 43 (10) : 1006 - 1014
  • [9] The therapeutic potential of BRD4 in cardiovascular disease
    Shigang Lin
    Lizhong Du
    Hypertension Research, 2020, 43 : 1006 - 1014
  • [10] BRD4 is a novel therapeutic target in melanoma
    Segura, Miguel F.
    Di Micco, Raffaella
    Zhang, Guangtao
    Zhang, Weijia
    Osman, Iman
    Zhou, Ming-Ming
    Hernando, Eva
    CANCER RESEARCH, 2012, 72